Yini i-Tildrakizumab: Ukusetshenziswa, Umthamo, Imiphumela Eceleni nokuningi

I-Tildrakizumab iyimithi kadokotela esiza ukwelapha i-psoriasis ye-plaque ephakathi nendawo kuya kokukhulu ezinganeni. Le mithi ejovwayo isebenza ngokugxila emaphrotheni athile ohlelweni lwakho lomzimba oluvikela izifo oluneqhaza ezimpawini ze-psoriasis.

Uma ubhekene nezindawo ze-psoriasis ezihlanganisa ingxenye enkulu yomzimba wakho noma ezingaphendulanga kahle kwezinye izindlela zokwelapha, udokotela wakho angase ancome i-tildrakizumab njengengxenye yohlelo lwakho lokwelapha. Yenzelwe ukusiza ukusula isikhumba sakho futhi kunciphise ukuvuvukala okubangela lezo zindawo ezingakhululeki, ezinama-scaly.

Yini i-Tildrakizumab?

I-Tildrakizumab uhlobo lomuthi obizwa ngokuthi i-monoclonal antibody eqondiswe ngqo ku-psoriasis. Ingowesigaba semithi eyaziwa ngokuthi i-biologics, eyenziwe ngamaseli aphilayo kunamakhemikhali.

Lo muthi uza njengesirinji noma ipeni eligcwaliswe ngaphambili olilayela ngaphansi kwesikhumba sakho (subcutaneously). Igama lomkhiqizo le-tildrakizumab yi-Ilumya, futhi ligunyazwe ngokuqondile ukwelapha i-psoriasis ye-plaque ephakathi nendawo kuya kokukhulu kubantu abadala abangaba ngabazongenela ukwelashwa okuhlelekile noma i-phototherapy.

Ngokungafani nama-creams noma amaphilisi athile, i-tildrakizumab isebenza ngaphakathi emzimbeni wakho ukuze ibhekane nembangela eyinhloko yokuvuvukala kwe-psoriasis. Ithathwa njengokwelashwa okuqondiwe ngoba igxila ezindleleni ezithile zohlelo lomzimba oluvikela izifo olubandakanyeka ekuthuthukisweni kwe-psoriasis.

Isetshenziselwani i-Tildrakizumab?

I-Tildrakizumab isetshenziswa ikakhulukazi ukwelapha i-psoriasis ye-plaque ephakathi nendawo kuya kokukhulu kubantu abadala. Lokhu kusho ukuthi kunqunywe uma i-psoriasis yakho ihlanganisa indawo enkulu yomzimba wakho noma ithinta kakhulu izinga lempilo yakho.

Udktora wakho angase ancome i-tildrakizumab uma unesifo se-psoriasis esingaphendulanga kahle ekwelashweni okusebenzayo njengama-creams nama-ointments. Futhi kuyindlela uma ungumuntu ofanelekayo ekwelashweni okuhlelekile, okusho ukwelashwa okusebenza emzimbeni wakho wonke kunokuba nje ebusweni besikhumba.

Umuthi wenzelwe ngqo i-plaque psoriasis, okuyilona fomu elivamile le-psoriasis. Lolu hlobo lubangela izindawo eziphakanyisiwe, ezibomvu ezimbozwe ngezilinganiso zesiliva ezingavela noma yikuphi emzimbeni wakho kodwa ngokuvamile zithinta izinqe zakho, amadolo, isikhumba sekhanda, nangemuva elingezansi.

Isebenza Kanjani I-Tildrakizumab?

I-Tildrakizumab isebenza ngokuvimba iphrotheni ethile ebizwa ngokuthi i-interleukin-23 (IL-23) ohlelweni lwakho lomzimba lokuzivikela. Le phrotheni idlala indima ebalulekile ekubangeleni ukuvuvukala nokukhula okusheshayo kwamaseli esikhumba okubonisa i-psoriasis.

Cabanga nge-IL-23 njengomthunywa otshela uhlelo lwakho lomzimba lokuzivikela ukuthi ludale ukuvuvukala esikhumbeni sakho. Ngokuvimba lo mthunywa, i-tildrakizumab isiza ukunciphisa impendulo yomzimba yokuzivikela engaphezu kwamandla eholela ezimpawini ze-psoriasis.

Lo muthi uthathwa njengomuthi oqinile ngokulinganisela phakathi kokwelashwa kwe-psoriasis. Ihlosiwe kunezeminye imithi emidala ehlelekile, okusho ukuthi inemiphumela embalwa ohlelweni lwakho lonke lomzimba lokuzivikela ngenkathi isasebenza ezimpawini ze-psoriasis.

Isenzo sokuvimba sisiza ukunciphisa ukuguqulwa okusheshayo kwamaseli esikhumba okudala lezo zindawo eziqine, ezinama-scaly. Ngokuhamba kwesikhathi, lokhu kungaholela esikhumbeni esicacile nokuncipha kokuvuvukala ezindaweni ezithintekile.

Kufanele Ngiyithathe Kanjani I-Tildrakizumab?

I-Tildrakizumab inikezwa njengomjovo ngaphansi kwesikhumba sakho, ngokuvamile ethangeni lakho, endaweni yesisu, noma engalweni engenhla. Umhlinzeki wakho wezempilo uzokufundisa ukuthi uzijove kanjani wena, noma ungenza lokho ehhovisi lezokwelapha.

Umuthi uza ngomjovo ozaliswe ngaphambili noma idivayisi yepeni elenza ukuzijova kube lula. Kuzodingeka uvumele umuthi ukuthi ufike ezingeni lokushisa legumbi ngaphambi kokujova, okuthatha imizuzu engaba ngu-30 ngemva kokuwukhipha esiqandisini.

Ungathatha i-tildrakizumab ngaphandle noma ngaphandle kokudla ngoba ijovwa esikhundleni sokuthathwa ngomlomo. Nokho, kufanele ujikeleze izindawo zokujova ukuvimbela ukucasuka kwesikhumba futhi ugweme ukujova ezindaweni lapho isikhumba sakho sithambile, sinamabala, noma sithinteka yi-psoriasis.

Ngaphambi komjovo ngamunye, hlanza izandla zakho ngokucophelela futhi uhlanze indawo yokujova nge-alcohol swab. Qiniseka ukuthi ulahla izinaliti ezisetshenzisiwe kanye nemijovo ngokuphepha esitsheni esibukhali.

Kufanele Ngiyithathe Isikhathi Esingakanani I-Tildrakizumab?

Abantu abaningi baqala ngomthamo wokuqala, kulandelwe omunye umthamo emavikini angu-4 kamuva, bese beqhubeka nemithamo njalo ngemva kwamasonto angu-12. Udokotela wakho uzonquma isimiso esiqondile esifanele isimo sakho esithile.

I-Psoriasis yisimo esingamahlala-khona, okusho ukuthi i-tildrakizumab ngokuvamile iyindlela yokwelapha yesikhathi eside. Abantu abaningi baqhubeka beyithatha izinyanga noma iminyaka ukuze bagcine isikhumba esicacile futhi bavimbele izimpawu ze-psoriasis ukuthi zingabuyi.

Ungase uqale ukuqaphela ukuthuthuka esikhumbeni sakho emasontweni ambalwa okuqala, kodwa kungathatha amasonto angu-12-16 ukubona imiphumela ephelele. Udokotela wakho uzoqapha inqubekela phambili yakho futhi angase alungise uhlelo lwakho lokwelapha ngokusekelwe ekutheni usabela kahle kangakanani.

Ungayeki ukuthatha i-tildrakizumab ngokuzumayo ngaphandle kokukhuluma nodokotela wakho kuqala. Ukuyeka kungazelelwe kungase kubangele izimpawu zakho ze-psoriasis ukuthi zibuye noma zibe zimbi.

Yiziphi Imiphumela Eceleni Ye-Tildrakizumab?

Njengayo yonke imithi, i-tildrakizumab ingabangela imiphumela emibi, nakuba kungewona wonke umuntu oyitholayo. Imiphumela eminingi emibi ithambile kuya esimweni esiphakathi nendawo futhi ingalawuleka ngokuqapha okufanele.

Nawa amanye imiphumela emibi evamile ongase uyithole:

• Ukutheleleka kwepheshana eliphezulu lokuphefumula njengomkhuhlane noma ukutheleleka kwamathambo
• Ukuphendula endaweni yokujova njengobubomvu, ukuvuvukala, noma ubuhlungu obuncane
• Ukuqunjelwa noma ukuphatheka kabi kwesisu
• Ubuhlungu emhlane noma ukuqaqamba kwemisipha
• Ukucindezeleka

Le miphumela emibi ejwayelekile ivamise ukuthuthuka njengoba umzimba wakho ujwayela umuthi, futhi abantu abaningi bangaqhubeka nokwelashwa kwabo ngaphandle kokuphazamiseka.

Ezinye izinto ezingavamile kodwa ezingathi sína zidinga ukunakekelwa kwezempilo ngokushesha:

• Izimpawu zokutheleleka okukhulu njengomkhuhlane, amaqhwa, noma ukukhwehlela okuqhubekayo
• Ukukhathala okungavamile noma ubuthakathaka
• Ukuphendula okukhulu komzimba okunezinkinga zokuphefumula noma ukuvuvukala
• Izimpawu ezintsha noma ezimbi kakhulu zesifo samathumbu esivuvukalayo
• Ukuphendula kwesikhumba ngaphandle kwendawo yokujova

Imiphumela emibi engavamile kodwa engathi sína ingabandakanya ingozi eyengeziwe yokutheleleka okuthile noma imiphumela engaba khona ekusebenzeni kwesibindi sakho. Udokotela wakho uzokuqapha njalo ngezivivinyo zegazi ukuze abambe noma yiziphi izinkinga ngokushesha.

Ubani Ongafanele Athathwe I-Tildrakizumab?

I-Tildrakizumab ayilungile kuwo wonke umuntu, futhi izimo ezithile zezempilo noma izimo zikwenza kungafaneleki noma zidinga izinyathelo zokuphepha ezikhethekile.

Akufanele uthathe i-tildrakizumab uma unokutheleleka okukhulu okusebenzayo noma yikuphi emzimbeni wakho. Lokhu kufaka phakathi ukutheleleka kwamagciwane, amagciwane, isikhunta, noma amapharasayithi angazange aphathwe futhi axazululwe.

Abantu abanezimo ezithile zezempilo badinga ukuhlolwa ngokucophelela ngaphambi kokuqala i-tildrakizumab:

• Umlando wokutheleleka okuphindaphindayo noma izimo ezandisa ingozi yokutheleleka
• Isifo samathumbu esivuvukalayo njengesifo sikaCrohn noma i-ulcerative colitis
• Imithi yokugomela yamuva ngemithi yokugomela ephilayo
• Isifo sofuba noma ukuchayeka esifubeni
• Ukutheleleka nge-Hepatitis B noma C

Udokotela wakho uzodinga ukuhlola lezi zimo ngokucophelela ngoba i-tildrakizumab ithinta amasosha akho omzimba futhi ingase iqhubekisele phambili izinkinga ezithile zezempilo.

Ukukhulelwa nokuncelisa kufuna ukucatshangelwa okukhethekile. Ngenkathi kunedatha elinganiselwe ekuvikelekeni kwe-tildrakizumab ngesikhathi sokukhulelwa, kufanele uxoxe ngezingozi nezinzuzo nodokotela wakho uma ukhulelwe, uhlela ukukhulelwa, noma uncelisa.

Igama Lomkhiqizo le-Tildrakizumab

Igama lomkhiqizo le-tildrakizumab yi-Ilumya. Leli yigama ozolibona ebhodleleni lakho lemithi kanye nokupakishwa kwemithi.

I-Ilumya yenziwa yi-Sun Pharmaceutical Industries futhi yavunywa yi-FDA ngonyaka ka-2018 ukwelapha i-psoriasis emaphakathi kuya kokukhulu ezinganeni. Yiyona kuphela inguqulo yegama lomkhiqizo le-tildrakizumab etholakalayo njengamanje.

Uma ukhuluma nodokotela wakho noma usokhemisi, ungabhekisa emuthini wakho njenge-tildrakizumab noma i-Ilumya - yimithi efanayo. Umshwalense wakho kanye nekhemisi kungase kusebenzise noma yiliphi igama lapho kucutshungulwa umuthi wakho.

Ezinye Izindlela Zokwelapha ze-Tildrakizumab

Eminye imithi eminingi ye-biologic isebenza ngendlela efanayo ne-tildrakizumab ekwelapheni i-psoriasis. Lezi ezinye izindlela zihlose amaprotheni ahlukene ohlelweni lomzimba lokuzivikela kodwa zihlose ukufeza imiphumela efanayo.

Ezinye izithiyo ze-IL-23 ezifana ne-tildrakizumab zihlanganisa i-guselkumab (Tremfya) kanye ne-risankizumab (Skyrizi). Le mithi isebenza ngendlela efanayo futhi inokusebenza okufanayo kanye namaphrofayili emiphumela emibi.

Ezinye izindlela zokwelapha ze-biologic zihlose izindlela ezihlukene zohlelo lomzimba lokuzivikela:

• Izithiyo ze-IL-17 ezifana ne-secukinumab (Cosentyx) kanye ne-ixekizumab (Taltz)
• Izithiyo ze-TNF ezifana ne-adalimumab (Humira) kanye ne-etanercept (Enbrel)
• Izithiyo ze-IL-12/23 ezifana ne-ustekinumab (Stelara)

Udokotela wakho uzokusiza ukhethe inketho engcono kakhulu ngokusekelwe esimweni sakho esithile, umlando wakho wezokwelapha, nokuthi usabele kanjani ekwelashweni kwangaphambilini. Umuthi ngamunye unohlelo lwawo lokulinganisa, iphrofayili yomphumela, kanye nokucatshangelwa.

Ingabe i-Tildrakizumab Ingcono Kune-Adalimumab?

Kokubili i-tildrakizumab ne-adalimumab ziyizindlela zokwelapha eziphumelelayo ze-psoriasis, kodwa zisebenza ngezindlela ezihlukene futhi zinezinzuzo ezihlukene. Ukukhetha "okungcono" kuncike ezidingweni zakho ngazinye kanye nesimo sakho sezokwelapha.

I-Tildrakizumab iqondise i-IL-23, kuyilapho i-adalimumab ivimba i-TNF-alpha. Izifundo zomtholampilo zikhomba ukuthi i-tildrakizumab ingase isebenze kangcono ekutholeni isikhumba esicacile noma esicishe sicace kwabanye abantu, ikakhulukazi labo abane-psoriasis ephakathi nendawo kuya kokukhulu.

Izinhlelo zokulinganisa ziyahluka kakhulu phakathi kwale mithi. I-Tildrakizumab inikezwa njalo ngamaviki ayi-12 ngemva kwemithamo yokuqala, kuyilapho i-adalimumab ngokuvamile idinga imijovo njalo ngemva kwamasonto amabili. Lokhu kulinganisa okungavamile nge-tildrakizumab kungase kube lula kwabanye abantu.

Amaphrofayili emiphumela emibi nawo ayahluka phakathi kwale mithi emibili. I-Adalimumab isitholakala isikhathi eside futhi inemininingwane eminingi yomhlaba wangempela, kuyilapho i-tildrakizumab isencane enokuxhumana okumbalwa kwezidakamizwa kanye nemiphumela ohlelweni olubanzi lomzimba lokuzivikela ezifweni.

Imibuzo Evame Ukubuzwa Mayelana ne-Tildrakizumab

Ingabe i-Tildrakizumab iphephile kubantu abanesifo sikashukela?

I-Tildrakizumab ngokuvamile ingasetshenziswa ngokuphepha kubantu abanesifo sikashukela, kodwa udokotela wakho uzodinga ukukuqapha eduze. Abantu abanesifo sikashukela bangase babe sengozini enkulu yokutheleleka, futhi i-tildrakizumab ingase futhi ithinte ikhono lomzimba wakho lokuzivikela ezifweni lokulwa nezifo.

Udokotela wakho cishe uzofuna ukuqinisekisa ukuthi isifo sakho sikashukela silawulwa kahle ngaphambi kokuqala i-tildrakizumab. Bangase futhi bancomise ukuhlolwa okuvamile ukuqapha noma yiziphi izimpawu zokutheleleka noma ezinye izinkinga.

Ngingenzani uma ngiphuthelwa ngengozi ukusebenzisa i-Tildrakizumab eningi kakhulu?

Uma ngengozi ujova i-tildrakizumab eningi kunaleyo ebekiwe, xhumana nodokotela wakho noma umhlinzeki wezempilo ngokushesha. Nakuba ukweqisa nge-tildrakizumab akuvamile ngenxa yomklamo wayo we-syringe ogcwaliswe ngaphambili, kubalulekile ukuthola iseluleko sezokwelapha.

Ungazami ukulungisa ngokususa umthamo wakho olandelayo noma ukushintsha uhlelo lwakho ngaphandle kosizo. Udokotela wakho uzokunikeza isiqondiso sokuthi uqhubeke kanjani ngokuphepha futhi angase afune ukukuqapha eduze ukuze abone imiphumela emibi.

Kufanele Ngenzeni Uma Ngeqe Umthamo We-Tildrakizumab?

Uma weqa umthamo we-tildrakizumab ohleliwe, yithathe ngokushesha lapho ukhumbula. Bese uqhubeka nohlelo lwakho lokulinganisa olujwayelekile kusukela ngaleso sikhathi kuqhubeke.

Ungaphindi imithamo noma uzame ukulungisa umthamo oweqiwe ngokuthatha imithi eyengeziwe. Xhumana nehhovisi likadokotela wakho uma ungaqiniseki ngesikhathi noma uma weqe imithamo eminingi, njengoba kungase kudingeke ukuthi balungise uhlelo lwakho lokwelashwa.

Ngingayeka Nini Ukuthatha I-Tildrakizumab?

Kufanele uyeke kuphela ukuthatha i-tildrakizumab ngaphansi kwesiqondiso sikadokotela wakho. Njengoba i-psoriasis iyisimo esingamahlalakhona, ukuyeka imithi cishe kuzobangela ukuthi izimpawu zakho zibuye ngokuhamba kwesikhathi.

Udokotela wakho angase ancome ukuyeka i-tildrakizumab uma uba nemiphumela emibi engathi sína, uthola izifo ezithile, noma uma i-psoriasis yakho ibilawulwa kahle isikhathi eside. Bazosebenza nawe ukuthuthukisa uhlelo lokuqapha isimo sakho ngemva kokuyeka imithi.

Ngingakwazi Ukugonywa Ngenkathi Ngithatha I-Tildrakizumab?

Ungathola imigomo eminingi ngenkathi uthatha i-tildrakizumab, kodwa kufanele ugweme imigomo ephilayo. Udokotela wakho uzoncoma ukuthola imigomo edingekayo ngaphambi kokuqala ukwelashwa uma kungenzeka.

Imigomo evamile efana nomgomo womkhuhlane, imigomo ye-COVID-19, neminye imigomo engasebenzi ngokuvamile iphephile ukuyithola ngenkathi use-tildrakizumab. Nokho, ngaso sonke isikhathi yazisa umhlinzeki wakho wezempilo ukuthi uthatha le mithi ngaphambi kokuthola noma yimuphi umgomo.